199 related articles for article (PubMed ID: 21496834)
1. The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
Boris RS; Benhammou J; Merino M; Pinto PA; Linehan WM; Bratslavsky G
J Urol; 2011 Jun; 185(6):2050-5. PubMed ID: 21496834
[TBL] [Abstract][Full Text] [Related]
2. Heterozygous germline FLCN mutation in Birt-Hogg-Dubé syndrome with bilateral renal hybrid oncocytic/chromophobe tumor and unilateral renal chromophobe cell carcinoma: a case report.
Li J; Liu F; Liu X; Hu Y; Liu Z; Shen Y; Wan J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2319-2325. PubMed ID: 36258004
[TBL] [Abstract][Full Text] [Related]
3. Sporadic hybrid oncocytic/chromophobe tumor of the kidney: a clinicopathologic, histomorphologic, immunohistochemical, ultrastructural, and molecular cytogenetic study of 14 cases.
Petersson F; Gatalica Z; Grossmann P; Perez Montiel MD; Alvarado Cabrero I; Bulimbasic S; Swatek A; Straka L; Tichy T; Hora M; Kuroda N; Legendre B; Michal M; Hes O
Virchows Arch; 2010 Apr; 456(4):355-65. PubMed ID: 20300772
[TBL] [Abstract][Full Text] [Related]
4. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
[TBL] [Abstract][Full Text] [Related]
5. [Birt-Hogg-Dubé syndrome: an update].
López V; Jordá E; Monteagudo C
Actas Dermosifiliogr; 2012 Apr; 103(3):198-206. PubMed ID: 21937013
[TBL] [Abstract][Full Text] [Related]
6. Renal cell tumour characteristics in patients with the Birt-Hogg-Dubé cancer susceptibility syndrome: a retrospective, multicentre study.
Benusiglio PR; Giraud S; Deveaux S; Méjean A; Correas JM; Joly D; Timsit MO; Ferlicot S; Verkarre V; Abadie C; Chauveau D; Leroux D; Avril MF; Cordier JF; Richard S;
Orphanet J Rare Dis; 2014 Oct; 9():163. PubMed ID: 25519458
[TBL] [Abstract][Full Text] [Related]
7. Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations.
Adley BP; Smith ND; Nayar R; Yang XJ
Arch Pathol Lab Med; 2006 Dec; 130(12):1865-70. PubMed ID: 17149965
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.
Lang M; Vocke CD; Merino MJ; Schmidt LS; Linehan WM
Mod Pathol; 2015 Nov; 28(11):1458-69. PubMed ID: 26428318
[TBL] [Abstract][Full Text] [Related]
9. Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome.
Schmidt LS; Nickerson ML; Warren MB; Glenn GM; Toro JR; Merino MJ; Turner ML; Choyke PL; Sharma N; Peterson J; Morrison P; Maher ER; Walther MM; Zbar B; Linehan WM
Am J Hum Genet; 2005 Jun; 76(6):1023-33. PubMed ID: 15852235
[TBL] [Abstract][Full Text] [Related]
10. Fluorescent and chromogenic in situ hybridization of CEN17q as a potent useful diagnostic marker for Birt-Hogg-Dubé syndrome-associated chromophobe renal cell carcinomas.
Kato I; Iribe Y; Nagashima Y; Kuroda N; Tanaka R; Nakatani Y; Hasumi H; Yao M; Furuya M
Hum Pathol; 2016 Jun; 52():74-82. PubMed ID: 26980015
[TBL] [Abstract][Full Text] [Related]
11. Emerging entities in renal cell neoplasia: thyroid-like follicular renal cell carcinoma and multifocal oncocytoma-like tumours associated with oncocytosis.
Eble JN; Delahunt B
Pathology; 2018 Jan; 50(1):24-36. PubMed ID: 29132724
[TBL] [Abstract][Full Text] [Related]
12. Case Report of Birt-Hogg-Dubé Syndrome: Germline Mutations of FLCN Detected in Patients With Renal Cancer and Thyroid Cancer.
Dong L; Gao M; Hao WJ; Zheng XQ; Li YG; Li XL; Yu Y
Medicine (Baltimore); 2016 May; 95(22):e3695. PubMed ID: 27258496
[TBL] [Abstract][Full Text] [Related]
13. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
[TBL] [Abstract][Full Text] [Related]
14. Distinctive expression patterns of glycoprotein non-metastatic B and folliculin in renal tumors in patients with Birt-Hogg-Dubé syndrome.
Furuya M; Hong SB; Tanaka R; Kuroda N; Nagashima Y; Nagahama K; Suyama T; Yao M; Nakatani Y
Cancer Sci; 2015 Mar; 106(3):315-23. PubMed ID: 25594584
[TBL] [Abstract][Full Text] [Related]
15. Renal tumors in the Birt-Hogg-Dubé syndrome.
Pavlovich CP; Walther MM; Eyler RA; Hewitt SM; Zbar B; Linehan WM; Merino MJ
Am J Surg Pathol; 2002 Dec; 26(12):1542-52. PubMed ID: 12459621
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of Birt-Hogg-Dubé associated renal carcinoma.
Murakami T; Sano F; Huang Y; Komiya A; Baba M; Osada Y; Nagashima Y; Kondo K; Nakaigawa N; Miura T; Kubota Y; Yao M; Kishida T
J Pathol; 2007 Apr; 211(5):524-531. PubMed ID: 17323425
[TBL] [Abstract][Full Text] [Related]
17. [DIAGNOSIS OF GENETIC VARIANT CARRIERS IN A PATIENT WITH ASYMPTOMATIC BIRT-HOGG-DUBÉ SYNDROME: A CASE REPORT].
Watari S; Ichikawa T; Hirasawa A; Shiraishi H; Tokunaga M; Kubota R; Kusumi N; Tsushima T; Shinno Y; Furuya M
Nihon Hinyokika Gakkai Zasshi; 2023; 114(2):61-65. PubMed ID: 38644188
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical characterization of renal tumors in patients with Birt-Hogg-Dubé syndrome.
Iribe Y; Kuroda N; Nagashima Y; Yao M; Tanaka R; Gotoda H; Kawakami F; Imamura Y; Nakamura Y; Ando M; Araki A; Matsushima J; Nakatani Y; Furuya M
Pathol Int; 2015 Mar; 65(3):126-32. PubMed ID: 25597876
[TBL] [Abstract][Full Text] [Related]
19. Birt-Hogg-Dubé syndrome: novel FLCN frameshift deletion in daughter and father with renal cell carcinomas.
Näf E; Laubscher D; Hopfer H; Streit M; Matyas G
Fam Cancer; 2016 Jan; 15(1):127-32. PubMed ID: 26342594
[TBL] [Abstract][Full Text] [Related]
20. Birt-Hogg-Dubé syndrome, a genodermatosis that increases risk for renal carcinoma.
Schmidt LS
Curr Mol Med; 2004 Dec; 4(8):877-85. PubMed ID: 15579035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
